Open Access
Subscription Access
Open Access
Subscription Access
Genome Editing as a Patentable Technology:A Future Debacle?
Subscribe/Renew Journal
Genome engineering by targeted editing is a revolutionary strategy for biological hacking which has attracted worldwide scientific attention. The technology, though in its naive state has already exhibited a huge potential in directing the progress of medical and agronomic fields. This has led to international legal clashes among research institutions in order to grasp the lucrative intellectual rights over such cash rich synthetic biology. However, commercialization of artificial genome manipulation techniques by breaching the ethical guidelines can have detrimental impacts on the quality of human life and cause social cataclysms. In this article, we have portrayed the crucial biosafety issues associated with genome editing and have also related the current global scenario regarding the patentability of this ‘unpredictable’ technology to the future of scientific advancements.
User
Subscription
Login to verify subscription
Font Size
Information
- J Watson, F Crick F, Molecular structure of deoxypentose nucleic acids, Nature, Vol 171, page 738-40, 1953.
- B J Gorman, Patent office as biosecurity gatekeeper: Fostering responsible science and building public trust in DIY science, The John Marshall Review of Intellectual Property Law, Vol 10, electronic version 423, 2011.
- D J Shea, Oversight of dual-use biological research: The national science advisory board for biosecurity, Congress Research Service RL electronic version 33342, 2007.
- B Barrangou, J A Doudna, Applications of CRISPR technologies in research and beyond. Nature Biotechnol, Vol 34, page 933-41, 2016.
- Method of the year, Nature Methods, Vol 9, 2011.
- Breakthrough of the year, Science, http://www.sciencemag.org/topic/2015-breakthrough-year, 2015.
- C Wang, L Shen, Y Fu, C Yan, K Wang, A simple CRISPR/Cas9 system for multiplex genome editing in rice, J Genetics Genomics, Vol 42, page 703-06, 2015.
- A Chin, CRISPR/Cas9 therapeutics: A technology overview, Oxford Biotechnology, 2015.
- Science Innovation Union, CRISPR/Cas9 therapeutics: A technology overview, Retrieved June 26, 2017, from: http://science-union.org/ articlelist/2015/9/9/crispr-cas9-therapeutics-a-technology-overview, 2015.
- B Ravi, Gene patents in India: Gauging policy by an analysis of the grants made by the Indian Patent Office, J Intellect Property Rights, Vol 18, page 323-29, 2013.
- K M Esvelt, A L Smidler, F Catteruccia, G M Church, Concerning RNA-guided gene drives for the alteration of wild populations, Elife, electronic version e03401, 2014.
- K A Oye, K Esvelt, E Appleton et al., Biotechnology regulating gene drives, Science, Vol 345, page 626-28, 2014.
- H Ledford, CRISPR, the disruptor, Nature, Vol 522, page 20-24, 2015.
- M Cheng, Britain approves controversial geneediting experiments, AP News, 2016.
- E Rodriguez, Ethical issues in genome editing using CRISPR/Cas9 system, J Clin Res Bioethics, Vol 7, electronic version 2, 2016.
- O Steven, Committee on Science, Technology, and Law; Policy and Global Affairs; National Academies of Sciences, Engineering, and Medicine, International Summit on Gene-Editing, 2015.
- F Collins, Statement on NIH funding of research using gene editing technologies in human embryos, The NIH Director-National Institutes of Health (NIH), 2015.
- J Gallagher, Scientists get ‘gene editing’ go ahead, BBC News (BBC).
- A Park, U.K. approves first studies of new gene editing technique CRISPR on human embryos, Time, 2016, February 1.
- A Joseph, Gene-editing, religion and one scientist’s quest to reconcile the two, Science, http://www.pbs.org/newshour/rundown/gene-editing-religion-scientist/, 2016.
- M Jinek, K Chylinski, I Fonfara, et al., A programmable dual-RNA-guided DNA endonuclease in adaptive bactierial immunity, Science, Vol 337, page 816-21, 2012.
- L Cong, F A Ran, D Cox, et al., Multiplex genome engineering using CRISPR/Cas systems, Science, Vol 339, page 819-23, 2013.
- Broad Institute, For journalists: Statement and background on the CRISPR patent process, Retrieved June 26, 2017, from: https://www.broadinstitute.org/crispr/journalists-statement-and-background-crispr-patent-process.
- H Ledford, Titanic clash over CRISPR patents turns ugly, Nature, Vol 537, page 460-61, 2016.
- J Akst, UC Berkeley receives CRISPR patent in Europe, The Scientist, electronic version 48987, 2017.
- H Ledford, Why the CRISPR patent verdict isn’t the end of the story, Nature, doi:10.1038/nature.2017.21510, 2017.
- T Sprink, D Eriksson, J Schiemann, F Hartung, Regulatory hurdles for genome editing: process- vs. product-based approaches in different regulatory contexts. Plant Cell Rep Vol 35, page 1493-1506, 2016.
- D Tal, Forecast: Biohacking superhumans: Future of human evolution P3. Quantum Run http://www.quantumrun.com/prediction/biohacking-superhumans-future-human-evolution-p3, 2016.
- A Joseph, Gene-editing, religion and one scientist’s quest to reconcile the two, Science, http://www.pbs.org/newshour/rundown/gene-editing-religion-scientist/, 2016.
Abstract Views: 388
PDF Views: 3